Search Results - "van Stein, Ruby M"

Is routine admission to a critical care setting following hyperthermic intraperitoneal chemotherapy for ovarian cancer necessary? by van Stein, Ruby M., Aronson, S. Lot, Sikorska, Karolina, Hendriks, Florine J., Hovinga, Els P., Houwink, Aletta P.I., Schutte, Peter F.E., Schooneveldt, Maaike S., De Kroon, Cor D., Sonke, Gabe S., van Driel, Willemien J.

“…Hyperthermic intraperitoneal chemotherapy (HIPEC) is increasingly being used in patients with stage III ovarian cancer undergoing interval cytoreductive…”
Get full text

Effects of Sampling Conditions and Environmental Factors on Fecal Volatile Organic Compound Analysis by an Electronic Nose Device by Berkhout, Daniel J C, Benninga, Marc A, van Stein, Ruby M, Brinkman, Paul, Niemarkt, Hendrik J, de Boer, Nanne K H, de Meij, Tim G J

“…Prior to implementation of volatile organic compound (VOC) analysis in clinical practice, substantial challenges, including methodological, biological and…”
Get full text

Turning up the heat does not affect quality of life by van Driel, Willemien J., Aronson, S. Lot, van Stein, Ruby M., Sonke, Gabe S.

“…KCI Citation Count: 0…”
Get full text

Health state utility and health-related quality of life measures in patients with advanced ovarian cancer by van Stein, Ruby M., Hendriks, Florine J., Retèl, Valesca P., de Kroon, Cor D., Lok, Christianne A.R., Sonke, Gabe S., de Ligt, Kelly M., van Driel, Willemien J.

“…•Real-world patient-reported data on HRQoL and health state utilities in advanced ovarian cancer are limited.•This cross-sectional study used validated…”
Get full text

Standardizing HIPEC and perioperative care for patients with ovarian cancer in the Netherlands using a Delphi-based consensus by van Stein, Ruby M., Lok, Christianne A.R., Aalbers, Arend G.J., H.J.T. de Hingh, Ignace, Houwink, Aletta P.I., Stoevelaar, Herman J., Sonke, Gabe S., van Driel, Willemien J.

“…•Implementation of HIPEC for ovarian cancer is ongoing, aiming to offer this treatment to all eligible patients in the Netherlands.•Standardization reduces…”
Get full text

Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer: A Review by van Stein, Ruby M, Aalbers, Arend G J, Sonke, Gabe S, van Driel, Willemien J

“…The peritoneal surface is a common site of disease in ovarian and colorectal cancer. Peritoneal metastases carry a poor prognosis, despite maximal therapeutic…”
Get more information

Future of HIPEC for ovarian cancer by Aronson, S. Lot, Stein, Ruby M., Sonke, Gabe S., Driel, Willemien J.

Get full text

Evaluation of external validity of the OVHIPEC‐1 trial in a real‐world population by Stein, Ruby M., Sikorska, Karolina, Aa, Maaike A., Sonke, Gabe S., Driel, Willemien J.

“…Objective The OVHIPEC‐1 trial (Phase III randomised clinical trial for stage III ovarian carcinoma randomising between interval cytoreductive surgery with or…”
Get full text

Primary cytoreductive surgery with or without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: The OVHIPEC-2 trial in progress by van Stein, Ruby M., Koole, Simone N., Sikorska, Karolina, Barton, Desmond P., Perrin, Lewis, Brennan, Donal, Zivanovic, Oliver, Mosgaard, Berit J., Fagotti, Anna, Colombo, Pierre-Emmanuel, Retel, Valesca P., Sonke, Gabe S., Van Driel, Willemien J.

“…Abstract only TPS6100 Background: The addition of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to interval cytoreductive surgery improves recurrence-free…”
Get full text